AzTrials
AzTrials

Degenerative Disc Disease5RSTS-2NCT03321357

Retest-reliability and At-home-assessment Feasibility of the 5R-STS

An observational study of Degenerative Disc Disease and Spondylolisthesis, run by Bergman Clinics at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The five-repetition sit-to-stand test has been validated and is used primarily in pulmonary medicine and cardiology, and has recently been shown to be a useful tool for the objective assessment of functional impairment in patients with degenerative diseases of the lumbar spine. Read more about this study

Who is it for?
Any age
What is being tested?
five-repetition sit-to-stand test
How many people
100 participants
Where
1 siteNetherlands
Study dates
8 Dec 2017to 21 Jun 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with symptomatic degenerative diseases of the lumbar spine that come in for surgical treatment

Who may be able to join

  • Degenerative diseases of the lumbar spine (Herniated disc, lumbar stenosis, spondylolisthesis, degenerative disc disease)
  • Symptoms of lower back pain, neurogenic claudication, or radiculopathy

Who cannot join

  • Hip or Knee prosthetics
  • Walking aides

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Bergman Clinics

    Naarden, 1411 GE

Other trials in Netherlands

About this study

Official title: Test-retest-reliability and At-home-assessment Feasibility of the Five-repetition Sit-to-stand Test (5R-STS)

The five-repetition sit-to-stand test has been validated and is used primarily in pulmonary medicine and cardiology, and has recently been shown to be a useful tool for the objective assessment of functional impairment in patients with degenerative diseases of the lumbar spine.

The goal of this study is to assess the possibility of supervised and unsupervised at-home-assessment. Validation of at-home-assessment would allow the 5R-STS to be easily used as a follow-up tool in clinical trials, for example.

Read the detailed description

Patients will perform three 5R-STS measurements:

  1. During outpatient clinics, time measured by the physician
  2. At home, time measured by partner/family
  3. At home, and assessed by producing a video recording of the 5R-STS performance that is subsequently sent and analyzed (time measured digitally)
Being tested
five-repetition sit-to-stand test
Medical subject headings
Intervertebral Disc Degeneration, Spondylolisthesis, Spondylosis, Spinal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • five-repetition sit-to-stand testDiagnostic test

    Also called 5R-STS

    An armless chair with a hard seat was stabilised by placing it against a wall. Seated participants were asked to come forward on the chair seat until the feet were flat on the floor and to fold their upper limbs across the chest. Participants were then instructed to stand up all the way and sit down once without using the upper limbs. For those unable to complete the initial manoeuvre or who required assistance, the test was terminated. If successful on the initial sit to stand, participants were then asked to stand up all the way and sit down landing firmly, as fast as possible, five times without using the arms. Timing with a stopwatch was started on the command 'go' and stopped at the end of the completed fifth stand; the time taken was recorded as the participant's score.

    (1) Jones et al.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 5R-STS

    Objective functional test measuring the amount of functional impairment.

    Measured: 0 months

Secondary outcomes (5)
  1. EQ-5D-3L

    Validated questionnaire measuring quality of life

    Measured: 0 months

  2. Oswestry Disability Index

    Validated questionnaire measuring functional disability

    Measured: 0 months

  3. VAS leg pain severity

    Validated questionnaire measuring pain

    Measured: 0 months

  4. VAS back pain severity

    Validated questionnaire measuring pain

    Measured: 0 months

  5. Roland Morris Disability Questionnaire

    Validated questionnaire measuring functional disability

    Measured: 0 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2017
  2. Study start8 Dec 2017
  3. Primary completion1 Jun 2018
  4. Study completion21 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03321357
Sponsor's protocol ID
5R-STS-2
Acronym
5RSTS-2
Status last verified
Jul 2018
First submitted
23 Oct 2017
Last updated
13 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Jones SE, Kon SS, Canavan JL, Patel MS, Clark AL, Nolan CM, Polkey MI, Man WD. The five-repetition sit-to-stand test as a functional outcome measure in COPD. Thorax. 2013 Nov;68(11):1015-20. doi: 10.1136/thoraxjnl-2013-203576. Epub 2013 Jun 19.

    PubMed 23783372
  • Staartjes VE, Klukowska AM, Stumpo V, Vandertop WP, Schroder ML. Identifying clusters of objective functional impairment in patients with degenerative lumbar spinal disease using unsupervised learning. Eur Spine J. 2024 Apr;33(4):1320-1331. doi: 10.1007/s00586-023-08070-z. Epub 2023 Dec 21.

    PubMed 38127138
  • Klukowska AM, Staartjes VE, Vandertop WP, Schroder ML. Predictors of five-repetition sit-to-stand test performance in patients with lumbar degenerative disease. Acta Neurochir (Wien). 2023 Jan;165(1):107-115. doi: 10.1007/s00701-022-05441-1. Epub 2022 Dec 7.

    PubMed 36477416
  • Staartjes VE, Klukowska AM, Schroder ML. Association of maximum back and leg pain severity with objective functional impairment as assessed by five-repetition sit-to-stand testing: analysis of two prospective studies. Neurosurg Rev. 2020 Oct;43(5):1331-1338. doi: 10.1007/s10143-019-01168-3. Epub 2019 Aug 26.

    PubMed 31451936
  • Staartjes VE, Beusekamp F, Schroder ML. Can objective functional impairment in lumbar degenerative disease be reliably assessed at home using the five-repetition sit-to-stand test? A prospective study. Eur Spine J. 2019 Apr;28(4):665-673. doi: 10.1007/s00586-019-05897-3. Epub 2019 Jan 24.

    PubMed 30680635

Questions about this trial

What is this clinical trial studying?

An observational study of Degenerative Disc Disease and Spondylolisthesis, run by Bergman Clinics at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

5R-STS (time frame: 0 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03321357, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in